Multicenter, Randomized, Open-Label Phase 3 Study to Investigate Efficacy and Safety of Liposomal Transcrocetin(LEAF-4L6715) Plus Standard of Care Vs Standard of Care Alone for Treatment of Patients with Acute Respiratory Distress Syndrome
Latest Information Update: 22 Oct 2024
At a glance
- Drugs LEAF 4L6715 (Primary)
- Indications Adult respiratory distress syndrome
- Focus Registrational; Therapeutic Use
- Sponsors LEAF4Life
- 22 Oct 2024 New trial record